Caffeine: Clinical Dose Ranges and What the Research Describes

What caffeine is

Caffeine is a methylxanthine alkaloid that occurs naturally in coffee, tea, cacao, and a range of other plants. It is the most widely consumed psychoactive substance in the world. Caffeine's primary mechanism of action is competitive antagonism of adenosine receptors in the brain — blocking the inhibitory signalling that builds up during wakefulness and contributes to sleep pressure.

In supplement contexts it appears most commonly as caffeine anhydrous (dehydrated caffeine, approximately 12% more potent by weight than caffeine in coffee), as well as in natural sources such as guarana extract and green tea extract. The dose calculation differs depending on the source and extraction method.

The clinical dose range

The European Food Safety Authority considers 400 mg/day from all sources as a safe habitual intake for healthy adults. Single doses above 200 mg may increase cardiovascular effects in sensitive individuals.

What trials have measured

Caffeine has one of the broadest and most consistent evidence bases of any supplement ingredient. Its effects are well-replicated across independent research groups and mechanistically understood.

For endurance exercise, meta-analyses of randomised controlled trials consistently find performance improvements in time trials and time-to-exhaustion tests at doses of 3–6 mg/kg body weight, which broadly corresponds to 200–400 mg for a 70 kg adult. Effects are seen in cycling, running, swimming, and rowing. A 2019 meta-analysis found an overall improvement in endurance performance of approximately 2–4%.

For strength and power, the evidence is more mixed. Some trials find small improvements in maximal strength and anaerobic power; others do not. The effect is smaller and less consistent than for endurance performance.

For cognitive performance — reaction time, sustained attention, working memory — caffeine at 100–300 mg produces consistent improvements in studies measuring objective performance, particularly in fatigued individuals. Effects in well-rested individuals are smaller but present.

Tolerance develops rapidly with habitual caffeine use, which attenuates many performance and alertness effects over days to weeks of regular consumption. Withdrawal — characterised by headache, fatigue, and irritability — occurs when habitual users cease consumption abruptly.

Underdosing and overdosing in commercial products

Unlike most supplement ingredients where underdosing is the primary concern, caffeine presents both directions of error in commercial products:

• High-dose pre-workouts: Some pre-workout formulas contain 400–600 mg per serving — at or above the upper safe daily intake, particularly problematic if the user also consumes dietary caffeine. The Scanner flags doses above the established safe range.
• Undisclosed caffeine from extracts: Guarana, green coffee bean, or green tea extract may contribute meaningful caffeine without a clearly disclosed total caffeine figure on the label.
• Underdosed nootropics: Some cognitive support products include 50–100 mg of caffeine — below the 150 mg lower bound of cognitive trial protocols.

Documented safety considerations

At the studied dose range (150–400 mg), caffeine is safe for healthy adults. Documented considerations include anxiety and jitteriness (particularly at higher doses), disruption of sleep onset and sleep architecture when consumed within 6 hours of sleep, elevated heart rate, and transient increases in blood pressure. Habitual high intake is associated with physical dependence. Caffeine is contraindicated at high doses in individuals with certain cardiac arrhythmias, and caution is warranted in pregnancy — UK and European health authorities recommend limiting caffeine in pregnancy to below 200 mg/day from all sources.

How Proco Scanner evaluates it

The Scanner identifies caffeine from all declared sources on a label — anhydrous, guarana, green tea extract — calculates total caffeine content where possible, and checks it against the 150–400 mg evidence-based range. Products with undisclosed caffeine from extracts are flagged for lack of dose transparency.

Proco Scanner reads any supplement label and surfaces what the published research describes for each ingredient — dose, evidence quality, and known considerations. Coming to iOS. Join the waitlist for early access.